2017 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

News

 

BD to Acquire Bard for $24 Billion

April 23, 2017 -- BD (Becton, Dickinson and Company) and CR Bard, Inc. announced a definitive agreement under which BD will acquire Bard for $317 per Bard …

Study Identifies Predictors of Renal Dysfunction After AAA Repair

April 19, 2017 -- A study of the predictors of renal complications after endovascular aneurysm repair (EVAR) and open repair of abdominal aortic aneurysms (AAAs) was published…

Study Evaluates EVAR Using Fenestrated-Branch Endografts Based on Supraceliac Sealing Zones

April 20, 2017 -- Gustavo S. Oderich, MD, et al conducted a prospective, nonrandomized study to evaluate manufactured fenestrated-branched endovascular aortic repair (EVA…

Trends in Use Reported for the Cook Zenith Fenestrated EVAR Device in the United States

April 20, 2017 -- In the Journal of Vascular Surgery, Jessica P. Simons, MD, et al reported on the trends in use of the Zenith fenestrated endovascular graft (Cook Medica…

Gore's Tigris Vascular Stent Evaluated in Multicenter French Experience

April 20, 2017 -- A study of a multicenter experience with the Tigris vascular stent (Gore & Associates) in France concluded that the device demonstrates continued good re…

Study Evaluates Impact of UK NICE Guideline for Leg Ulcers on Treatment Referrals

April 19, 2017 -- Huw O.B. Davies, MD, et al conducted an evaluation of the impact of the United Kingdom's National Institute for Health and Care Excellence (NICE) Clinica…

Click here for more News coverage

Current Supplement

Sponsored by BOSTON SCIENTIFIC CORPORATION

Shaped and Sized for Embolization Success

Expert Case Experiences

Current European Supplement

Sponsored by VASCUTEK LTD.

EVARlution

More options and more solutions to treat complex AAA anatomy.

Featured Center

 

Embolization

advertisement

 
Vascular Market Price  Change
Abbott Laboratories $44.01  1.10%
AstraZeneca PLC $30.28  1.75%
Avinger $0.56  -3.15%
Boston Scientific Corporation $25.56  2.82%
Cardinal Health $72.45  -0.07%
Cardiovascular Systems Inc. $29.45  2.19%
CR Bard Inc. $304.10  20.16%
Edwards Lifesciences Corp. $97.87  0.10%
Endologix Inc. $7.03  1.44%
Vascular Market Price  Change
Johnson and Johnson $122.75  0.81%
Lombard Medical, Inc. $0.54  -6.24%
Medtronic, Inc. $80.81  0.41%
Merit Medical Systems, Inc. $30.15  3.97%
Penumbra, Inc. $84.75  0.18%
Stryker $134.19  0.94%
Teleflex Inc. $201.27  0.88%
The Medicines Company $51.41  -0.81%
The Spectranetics Corporation $28.00  2.38%

@EVToday

Stay current: Follow Endovascular Today on Twitter @EVToday

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.